HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,335,863 | -27.4% | 46,122 | -35.5% | 0.01% | -20.0% |
| Q2 2023 | $7,352,048 | -9.7% | 71,483 | -4.2% | 0.01% | -16.7% |
| Q1 2023 | $8,142,630 | -17.9% | 74,607 | -14.4% | 0.01% | -20.0% |
| Q4 2022 | $9,918,922 | +66.7% | 87,161 | -9.3% | 0.02% | +50.0% |
| Q3 2022 | $5,949,000 | -55.6% | 96,137 | -42.7% | 0.01% | -52.4% |
| Q2 2022 | $13,393,000 | +15.0% | 167,920 | +51.6% | 0.02% | +31.2% |
| Q1 2022 | $11,651,000 | -29.6% | 110,731 | -27.9% | 0.02% | -27.3% |
| Q4 2021 | $16,556,000 | -2.0% | 153,634 | -0.3% | 0.02% | -12.0% |
| Q3 2021 | $16,887,000 | +17.7% | 154,166 | +0.6% | 0.02% | +19.0% |
| Q2 2021 | $14,346,000 | -10.1% | 153,205 | -11.6% | 0.02% | -19.2% |
| Q1 2021 | $15,959,000 | +57.8% | 173,387 | +25.4% | 0.03% | +44.4% |
| Q4 2020 | $10,112,000 | +50.3% | 138,231 | +59.6% | 0.02% | +28.6% |
| Q3 2020 | $6,726,000 | +113.3% | 86,595 | +52.6% | 0.01% | +100.0% |
| Q2 2020 | $3,154,000 | +56.3% | 56,738 | -16.5% | 0.01% | +16.7% |
| Q1 2020 | $2,018,000 | -32.0% | 67,982 | -16.9% | 0.01% | 0.0% |
| Q4 2019 | $2,967,000 | +28.2% | 81,794 | -3.9% | 0.01% | 0.0% |
| Q3 2019 | $2,314,000 | -1.7% | 85,070 | -13.6% | 0.01% | 0.0% |
| Q2 2019 | $2,355,000 | – | 98,438 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |